9 Recruiting Relapsed Or Refractory Multiple Myeloma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Relapsed Or Refractory Multiple Myeloma
Top Recruiting Relapsed Or Refractory Multiple Myeloma Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
📍 Local Institution - 0046 — Mobile, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma
📍 Princess Margaret Hospital — Toronto, Ontario
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
📍 University of Arizona Cancer Center /ID# 285339 — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
📍 Research Site — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
📍 University of Alabama at Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
📍 Local Institution - 0366 — Los Alamitos, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
📍 City of Hope — Duarte, California
View Study & Checklist ➔